Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Anyone have guess on where we go from here?
View:
Post by SamuelSamuelSam on Nov 18, 2015 4:29pm

Anyone have guess on where we go from here?

Anyone have guess on where we go from here?
Comment by PharmaGuy42 on Nov 18, 2015 4:31pm
imo: We're pretty much done until Febrary. Simple as that.
Comment by Gary1959 on Nov 18, 2015 4:40pm
3 months will go fast. We will get it done in march
Comment by Kveinot on Nov 18, 2015 4:42pm
Does anyone have stats on what percentage fail the advisory committee yet still obtain fda approval?
Comment by DamnYankees on Nov 18, 2015 4:47pm
I suppose that Telesta will have to engage in some discussion with the FDA to see whether MCNA is approvable under its current submission platform. Somehow Valstar got approved after an Adcomm rejection and few would concur that it is a more substantive treatment than MCNA. Its not over yet but this will hurt.
Comment by Frogger2 on Nov 18, 2015 5:10pm
I can't remember where exactly but I did read that Berendt does have a back up plan. I hope he unveils this sooner rather than later. I was able to listen today but did read the uopdates, it seemed like the committee for the most part were looking for reasons not approve rather than what it did do for the patients involved in the study and the good it could do.  There was also a comment ...more  
Comment by ROIHunter on Nov 18, 2015 4:41pm
Company has $40m in cash.  While 2/3 of Advisory Comm said no, 1/3 said yes and were quite enthusiastic.  Will be very difficult to reject the drug outright esp on fast track.  If they do then the drug is likely dead in the water and never to be developed.  Even the negative opinions almost to a person wanted to approve the drug and or thought it would do little or no harm ...more  
Comment by SteveMcM on Nov 18, 2015 4:48pm
Found it interesting that 4 of 6 bladder cancer doctors voted yes.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities